Global GBS (Group B Streptococcus) Testing Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global GBS (Group B Streptococcus) Testing Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global GBS (Group B Streptococcus) Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The scientific name of GBS is Streptococcus agalactiae, also known as group B Streptococcus. It normally lives in the vagina and rectum. It is an opportunistic pathogenic bacteria. Invasive infections are most common in neonates, the elderly, and those with predisposing factors (i.e., pregnancy, diabetes, and immunocompromise). Generally, GBS infection in normal healthy people does not cause illness.According to research, about 10% to 30% of pregnant women have GBS vaginally resident, and 40% to 70% of them will be passed to their newborns during delivery. If newborns carry GBS, about 1% to 3% will develop early invasive infection, of which 5% will lead to death. Infections in pregnant women manifest as bacteremia, urinary tract infection, fetal membrane infection, endometrial infection and wound infection.

The Global Info Research report includes an overview of the development of the GBS (Group B Streptococcus) Testing industry chain, the market status of Newborn (Microbiological Culture Method, Fluorescence Quantitative PCR Method), Elderly (Microbiological Culture Method, Fluorescence Quantitative PCR Method), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of GBS (Group B Streptococcus) Testing.

Regionally, the report analyzes the GBS (Group B Streptococcus) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global GBS (Group B Streptococcus) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the GBS (Group B Streptococcus) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the GBS (Group B Streptococcus) Testing industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Microbiological Culture Method, Fluorescence Quantitative PCR Method).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the GBS (Group B Streptococcus) Testing market.

Regional Analysis: The report involves examining the GBS (Group B Streptococcus) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the GBS (Group B Streptococcus) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to GBS (Group B Streptococcus) Testing:

Company Analysis: Report covers individual GBS (Group B Streptococcus) Testing manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards GBS (Group B Streptococcus) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Newborn, Elderly).

Technology Analysis: Report covers specific technologies relevant to GBS (Group B Streptococcus) Testing. It assesses the current state, advancements, and potential future developments in GBS (Group B Streptococcus) Testing areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the GBS (Group B Streptococcus) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

GBS (Group B Streptococcus) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Microbiological Culture Method
Fluorescence Quantitative PCR Method
Immunochromatography
Other

Market segment by Application
Newborn
Elderly
Pregnant Woman
Other

Major players covered
Zhuhai DL Biotech
Meikang Biotechnology
Biomerieux
Shandong Boko Biotechnology
Barrett Bio
Luminex
Guangdong Sunshine Biotechnology
Shengxiang Biotechnology
Borcheng
Guangzhou Huaao Biotechnology
Kayudi Biotechnology
Suzhou Tianlong Biotechnology
Beijing KingWolf Biology
Guangzhou Micron Biotechnology
Shanghai Suchuang Diagnostic Products
Certest Biotec S.L.
Thermo Fisher
AtilaBiosystems

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe GBS (Group B Streptococcus) Testing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of GBS (Group B Streptococcus) Testing, with price, sales, revenue and global market share of GBS (Group B Streptococcus) Testing from 2019 to 2024.

Chapter 3, the GBS (Group B Streptococcus) Testing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the GBS (Group B Streptococcus) Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and GBS (Group B Streptococcus) Testing market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of GBS (Group B Streptococcus) Testing.

Chapter 14 and 15, to describe GBS (Group B Streptococcus) Testing sales channel, distributors, customers, research findings and conclusion.